KYMERA THERAPEUTICS, INC. (KYMR) FY2026 Q3 Balance Sheet
Published Source: Form 10-Q on SEC EDGAR filed (opens in a new tab)
Balance Sheet
Swipe to see the full flow
Chart details
KYMERA THERAPEUTICS, INC. (KYMR) FY2026 Q3 Balance Sheet
Balance sheet as of 2026-09-30. The chart shows assets, liabilities and equity at that date.
- Assets
- 1,767,269,000 US dollars
- Current assets
- 998,592,000 US dollars
- Non-current assets
- 768,677,000 US dollars
- Liabilities
- 152,742,000 US dollars
- Current liabilities
- 89,723,000 US dollars
- Non-current liabilities
- 63,019,000 US dollars
- Equity
- 1,614,527,000 US dollars
- Marketable securities (Note 4)
- 597,840,000 US dollars
- Cash and cash equivalents
- 373,374,000 US dollars
- Prepaid expenses and other current assets
- 27,378,000 US dollars
- Marketable securities, non-current (Note 4)
- 674,669,000 US dollars
- Right-of-use assets, operating leases
- 40,444,000 US dollars
- Property and equipment, net (Note 6)
- 38,242,000 US dollars
- Other non-current assets
- 9,113,000 US dollars
- Restricted cash
- 6,209,000 US dollars
- Accrued expenses (Note 8)
- 63,315,000 US dollars
- Operating lease liabilities
- 12,209,000 US dollars
- Accounts payable
- 11,923,000 US dollars
- Finance lease liabilities
- 1,371,000 US dollars
- Other current liabilities
- 905,000 US dollars
- Deferred revenue
- 0 US dollars
- Operating lease liabilities, net of current portion
- 62,417,000 US dollars
- Finance lease liabilities, net of current portion
- 602,000 US dollars
- Deferred revenue, net of current portion
- 0 US dollars
- Additional paid-in capital
- 2,957,658,000 US dollars
- Common stock, $0.0001 par value; 150,000,000 shares authorized at September 30, 2026 and December 31, 2025, 85,325,503 and 81,323,532 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively
- 9,000 US dollars
- Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of September 30, 2026 and December 31, 2025; 0 shares issued and outstanding as of September 30, 2026 and December 31, 2025
- 0 US dollars
- Accumulated deficit
- negative 1,328,405,000 US dollars
- Accumulated other comprehensive (loss) income
- negative 14,735,000 US dollars
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
